105 related articles for article (PubMed ID: 27791265)
1. GLUL Promotes Cell Proliferation in Breast Cancer.
Wang Y; Fan S; Lu J; Zhang Z; Wu D; Wu Z; Zheng Y
J Cell Biochem; 2017 Aug; 118(8):2018-2025. PubMed ID: 27791265
[TBL] [Abstract][Full Text] [Related]
2. High expression of glutamate-ammonia ligase is associated with unfavorable prognosis in patients with ovarian cancer.
Fan S; Wang Y; Zhang Z; Lu J; Wu Z; Shan Q; Sun C; Wu D; Li M; Sheng N; Xie Y; Zheng Y
J Cell Biochem; 2018 Jul; 119(7):6008-6015. PubMed ID: 29575012
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
Menendez JA; Vellon L; Colomer R; Lupu R
Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
[TBL] [Abstract][Full Text] [Related]
4. MTDH mediates trastuzumab resistance in HER2 positive breast cancer by decreasing PTEN expression through an NFκB-dependent pathway.
Du C; Yi X; Liu W; Han T; Liu Z; Ding Z; Zheng Z; Piao Y; Yuan J; Han Y; Xie M; Xie X
BMC Cancer; 2014 Nov; 14():869. PubMed ID: 25417825
[TBL] [Abstract][Full Text] [Related]
5. Glutamine synthetase regulates the immune microenvironment and cancer development through the inflammatory pathway.
Xuan DTM; Wu CC; Wang WJ; Hsu HP; Ta HDK; Anuraga G; Chiao CC; Wang CY
Int J Med Sci; 2023; 20(1):35-49. PubMed ID: 36619229
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-140-5p suppresses invasion and proliferation of glioma cells by targeting glutamate-ammonia ligase (GLUL).
Zhang R; Zhu JC; Hu H; Lin QY; Shao W; Ji TH
Neoplasma; 2020 Mar; 67(2):371-378. PubMed ID: 31986891
[TBL] [Abstract][Full Text] [Related]
7. Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells.
Ostrander JH; Daniel AR; Lofgren K; Kleer CG; Lange CA
Cancer Res; 2007 May; 67(9):4199-209. PubMed ID: 17483331
[TBL] [Abstract][Full Text] [Related]
8. Escherichia coli-derived and Staphylococcus aureus-derived extracellular vesicles induce MUC5AC expression via extracellular signal related kinase 1/2 and p38 mitogen-activated protein kinase in human airway epithelial cells.
Bae CH; Choi YS; Song SY; Kim YK; Kim YD
Int Forum Allergy Rhinol; 2017 Jan; 7(1):91-98. PubMed ID: 27595564
[TBL] [Abstract][Full Text] [Related]
9. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
10. Connexin-43 regulates p38-mediated cell migration and invasion induced selectively in tumour cells by low doses of γ-radiation in an ERK-1/2-independent manner.
Ghosh S; Kumar A; Tripathi RP; Chandna S
Carcinogenesis; 2014 Feb; 35(2):383-95. PubMed ID: 24045413
[TBL] [Abstract][Full Text] [Related]
11. Hexachlorobenzene modulates the crosstalk between the aryl hydrocarbon receptor and transforming growth factor-β1 signaling, enhancing human breast cancer cell migration and invasion.
Miret N; Pontillo C; Ventura C; Carozzo A; Chiappini F; Kleiman de Pisarev D; Fernández N; Cocca C; Randi A
Toxicology; 2016 Jul; 366-367():20-31. PubMed ID: 27519288
[TBL] [Abstract][Full Text] [Related]
12. PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim.
Park SH; Ito K; Olcott W; Katsyv I; Halstead-Nussloch G; Irie HY
Breast Cancer Res; 2015 Jun; 17(1):86. PubMed ID: 26084280
[TBL] [Abstract][Full Text] [Related]
13. Notch3-mediated regulation of MKP-1 levels promotes survival of T acute lymphoblastic leukemia cells.
Masiero M; Minuzzo S; Pusceddu I; Moserle L; Persano L; Agnusdei V; Tosello V; Basso G; Amadori A; Indraccolo S
Leukemia; 2011 Apr; 25(4):588-98. PubMed ID: 21263446
[TBL] [Abstract][Full Text] [Related]
14. PGC-1β regulates HER2-overexpressing breast cancer cells proliferation by metabolic and redox pathways.
Victorino VJ; Barroso WA; Assunção AK; Cury V; Jeremias IC; Petroni R; Chausse B; Ariga SK; Herrera AC; Panis C; Lima TM; Souza HP
Tumour Biol; 2016 May; 37(5):6035-44. PubMed ID: 26602383
[TBL] [Abstract][Full Text] [Related]
15. Functional Proteomics of Breast Cancer Metabolism Identifies GLUL as Responder during Hypoxic Adaptation.
Bernhardt S; Tönsing C; Mitra D; Erdem N; Müller-Decker K; Korf U; Kreutz C; Timmer J; Wiemann S
J Proteome Res; 2019 Mar; 18(3):1352-1362. PubMed ID: 30609375
[TBL] [Abstract][Full Text] [Related]
16. BMP9 inhibits proliferation and metastasis of HER2-positive SK-BR-3 breast cancer cells through ERK1/2 and PI3K/AKT pathways.
Ren W; Liu Y; Wan S; Fei C; Wang W; Chen Y; Zhang Z; Wang T; Wang J; Zhou L; Weng Y; He T; Zhang Y
PLoS One; 2014; 9(5):e96816. PubMed ID: 24805814
[TBL] [Abstract][Full Text] [Related]
17. [The role of Smad4 and MAPK proteins in signal transduction pathway in non-small cell lung cancer].
Tong XD; Liu HX; Zhao HR; Xu SG; Li Y; Han LB; Zhang L
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):741-5. PubMed ID: 17366784
[TBL] [Abstract][Full Text] [Related]
18. A bidirectional "alpha(v)beta(3) integrin-ERK1/ERK2 MAPK" connection regulates the proliferation of breast cancer cells.
Vellon L; Menendez JA; Lupu R
Mol Carcinog; 2006 Oct; 45(10):795-804. PubMed ID: 16705745
[TBL] [Abstract][Full Text] [Related]
19. Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer.
Garcia-Recio S; Fuster G; Fernandez-Nogueira P; Pastor-Arroyo EM; Park SY; Mayordomo C; Ametller E; Mancino M; Gonzalez-Farre X; Russnes HG; Engel P; Costamagna D; Fernandez PL; Gascón P; Almendro V
Cancer Res; 2013 Nov; 73(21):6424-34. PubMed ID: 24030979
[TBL] [Abstract][Full Text] [Related]
20. p38 mitogen-activated protein kinase pathway is involved in protein kinase Calpha-regulated invasion in human hepatocellular carcinoma cells.
Hsieh YH; Wu TT; Huang CY; Hsieh YS; Hwang JM; Liu JY
Cancer Res; 2007 May; 67(9):4320-7. PubMed ID: 17483345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]